Advertisement

Characterisation of ExoPr0 exosomes derived from proliferating GMP-grade CTX cells

      Exosomes are nanosized, cell-secreted, lipid bilayer vesicles containing multiple transmembrane proteins and complex cargoes (nucleic acids, metabolites, proteins and lipids) capable of being delivered to target cells. As such they offer a novel methodology for drug delivery and represent an innovative and rapidly developing new class of therapies. However, the success of this new therapeutic approach in clinical settings will be dependent on several challenges being overcome such as the standardisation of exosome isolation and storage procedures and, improved product characterisation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect